←Back to Expert Scholars
Translational Medicine / 转化医学Pediatric Sarcoma Drug Development
Richard Gorlick
MD
🏢MD Anderson Cancer Center🌐USA
Division Head of Pediatrics
80
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Richard Gorlick has led pediatric sarcoma drug development and the Pediatric Preclinical Testing Consortium for decades. His work at MD Anderson advances clinical translation of novel agents in osteosarcoma and other rare pediatric cancers. He has shaped national pediatric oncology trial strategy.
Share:
🧪Research Fields 研究领域
pediatric sarcoma
osteosarcoma
preclinical testing
drug development
COG
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Richard Gorlick 的研究动态
Follow Richard Gorlick's research updates
留下邮箱，当我们发布与 Richard Gorlick（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment